Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,938.00 0.00 (0.00%)

Bid:

1,802.00

Ask:

1,999.00

Spread: 197.00 (10.932%)

Market Cap: £77.72b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK vaccine given green light for all adults in Europe

(Sharecast News) - The European Commission has approved GSK's respiratory syncytial virus (RSV) vaccine for use in all adults, the drugs giant announc...

IN BRIEF: GSK drug approved in China to treat uncontrolled asthma

GSK PLC - London-based pharmaceuticals company - Says China's National Medical Products Administration has approved Trelegy Ellipta (fluticasone furo...

IN BRIEF: RTW Biotech welcomes GSK deal to buy RAPT Therapeutics

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Notes GSK PLC's announcement on Tuesday that it has agreed to ac...

GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug

GSK gains global rights to ozureprubart, excluding parts of Asia *

Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake

Shionogi doubles stake in ViiV Healthcare to ⁠21.7% *

LONDON MARKET OPEN: FTSE 100 sinks further as tariff fears grow

(Alliance News) - Stock prices in London slid further on Tuesday morning for the second day, as tariff threats from the US continued to unsettle inves...

GSK boosts pipeline with USD2.2 billion purchase of RAPT Therapeutics

(Alliance News) - GSK PLC on Tuesday announced the USD2.2 billion acquisition of RAPT Therapeutics Inc, a California-based clinical-stage biopharmaceu...

LONDON BRIEFING: UK unemployment flat; GSK buys RAPT Therapeutics

(Alliance News) - The UK unemployment rate was steady while regular earnings growth slowed, GSK agrees to buy biopharmaceutical firm RAPT Therapeutics...